`
Transparency Market
Research
Dilated Cardiomyopathy Therapeutics Market - Global
Industry Analysis, Pipeline Analysis, Size, Share,
Growth, Trends and Forecast 2014 - 2020
Published Date
2015-03-20
90 Page Report
Buy Now
Request Sample
Press Release
Dilated Cardiomyopathy Therapeutics Market Expected to Reach
USD 0.33 billion Globally in 2020
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
sales@transparencymarketresearch.com
Dilated Cardiomyopathy
Therapeutics Market
REPORT DESCRIPTION
Dilated Cardiomyopathy Therapeutics Market - Global Industry Analysis,
Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020
According to a new market report published by Transparency Market Research "Dilated
Cardiomyopathy Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share,
Growth, Trends and Forecast, 2014 - 2020," the global dilated cardiomyopathy market was
valued at USD 651.0 million in 2013 and is estimated to reach USD 328.6 million in 2020
declining at a CAGR of (7.0%) from 2014 to 2020.
Dilated cardiomyopathy (DCM) is one of the myocardium disorders associated with cardiac
dysfunction. Hypertrophic, dilated, arrhythmogenic right ventricular and restrictive
cardiomyopathies represent the four major types of cardiomyopathies, and the others fall under
unclassified category. DCM accounts for one of the major causes of heart failure and is
characterized by the presence of dilated heart muscles which lead to enlargement of the heart.
This in turn, hampers blood pumping capacity of the heart and with time, DCM spreads to the
right ventricle, atria and ultimately results in heart failure. The occurrence of dilated
cardiomyopathy in males is more prevalent than in females at a ratio of 3:1. Patients with mild
DCM can lead normal lives by regular intake of medication along with some...